Treatment for Alzheimer Disease-Sex and Gender Effects Need to Be Explicitly Analyzed and Reported in Clinical Trials

Janice B Schwartz^{1

2}, Sandra Weintraub^{3

4}

Affiliations

¹ Department of Medicine, University of California, San Francisco.
² Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.
³ Department ofPsychiatry and Behavioral Science, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
⁴ Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Free article

Comment

Janice B Schwartz et al. JAMA Netw Open. 2021.

Free article

. 2021 Sep 1;4(9):e2124386.

doi: 10.1001/jamanetworkopen.2021.24386.

Janice B Schwartz^{1

2}, Sandra Weintraub^{3

4}

¹ Department of Medicine, University of California, San Francisco.
² Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.
³ Department ofPsychiatry and Behavioral Science, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
⁴ Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

No abstract available

Comment on

Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis.
Martinkova J, Quevenco FC, Karcher H, Ferrari A, Sandset EC, Szoeke C, Hort J, Schmidt R, Chadha AS, Ferretti MT. Martinkova J, et al. JAMA Netw Open. 2021 Sep 1;4(9):e2124124. doi: 10.1001/jamanetworkopen.2021.24124. JAMA Netw Open. 2021. PMID: 34515784 Free PMC article.